4952
M. Murakata, M. Kimura / Tetrahedron Letters 51 (2010) 4950–4952
Komuro, E.; Kato, Y.; Tamura, K.; Cynshi, O.; Kodama, T.; Niki, E. Arch. Biochem.
Biophys. 1997, 342, 236; (c) Noguchi, N.; Okimoto, Y.; Tsuchiya, J.; Cynshi, O.;
Kodama, T.; Niki, E. Arch. Biochem. Biophys. 1997, 347, 141.
tion ofa substantialamount oftheby-product mixture(entries4 and
5).7 However, the yield of 10 was diminished considerably when the
reaction was carried out at 0 °C (Table 1, entry 6).8,9
2. (a) Nishinaga, A.; Itahara, T.; Matsuura, T.; Berger, S.; Henes, G.; Rieker, A. Chem.
Ber. 1976, 109, 1530; rearrangement of quinol catalysed by bases or acids has
reported, see: (b) Abe, Y. Bull. Chem. Soc. Jpn. 1943, 18, 93; (c) Although this type
of rearrangement in the present paper should be called ‘quinol-hydroquinone
rearrangement’, we use the term ‘dienone-phenol rearrangement’ as a well-
known expression.
Having establishedthe reaction conditions suitable for the gener-
ation of the desired dienone intermediate 10, its rearrangement to
the penultimate hydroquinone 13 was then examined under basic
conditions. Upon exposure of 10 to 3 equiv of potassium tert-butox-
ide in DMF at room temperature, the expected ‘dienone-phenol rear-
rangement’ did really occur to furnish the hydroquinone 13,10 which
was immediately treated with methanesulfonic acid to yield the tar-
get molecule, BO-653 1, directly, in 65% yield, with neither initiation
of rearrangement nor removal of tertiary butyl moiety.11 Although
the exact mechanism for the generation of the hydrofuran moiety
of 1 from the hydroquinone intermediate 13 is not clear, it is pre-
sumed to take place only under acidic conditions through either a
substitution pathway (via 13) or an addition–elimination pathway
(via 13–11–12)10a as 1 was not detected under the basic conditions
initiating the rearrangement. Overall yield of 1 from the starting
benzoquinone 8 was 53% in four steps without including any se-
quence of the protection–deprotection steps (Scheme 4).
In conclusion, we have established an alternative procedure
capable of producing 4,6-di-tert-butyl-2,2-dipentyl-2,3-dihydro-5-
benzofuranol (BO-653) 1, a potent antiathrogenic antioxidant, in
53% overall yield starting from a readily accessible starting material
8 through a sequence of four steps of reactions by the application of
the base-promoted dienone-phenol rearrangement reaction in the
key step.
3. Compound 9: 1H NMR (CDCl3) d 1.22 (18H, s), 2.63 (2H,s), 3.58 (1H, s), 3.72 (3H,
s), 6.61 (2H, s).
4. Precedents of the reactions between benzoquinones and nucleophiles. For ester
enolates, see: (a) Fischer, A.; Henderson, G. N. Tetrahedron Lett. 1983, 24, 131.
and references cited therein; For alkyllithiums and alkylmagnesium bromides,
see: (b) Liotta, D.; Saindane, M.; Barnum, C. J. Org. Chem. 1981, 46, 3369. and
references cited therein.
5. (a) Schlenk, W.; Schlenk, W., Jr. Chem. Ber. 1929, 62, 920; (b) Wakefield, B. J.
Organomagnesium Methods in Organic Synthesis; Academic Press: London, 1995;
(c)Grignard Reagents New Developments; Richey, H. G., Jr., Ed.; Wiley: New York,
2000.
6. Bu2Mg in place of Pen2Mg was used for the preliminary examination because of
commercial availability.
7. General procedure is as follows: Under an argon atmosphere, to a suspension of
Mg (10.71 mmol) in Et2O (10 mL) under vigorous stirring was added dropwise
1,2-dibromoethane (10.71 mmol) keeping a gentle reflux and the stirring was
continued at rt for 1.5 h. To the resulting suspension was added a solution of
PenMgBr in Et2O (4.31 mL, 8.62 mmol) at rt. The resulting clear solution was
added dropwise to
a solution of the ester 9 in Et2O (2.85 mmol) at the
temperature described in Table 1, and the stirring was continued for 18 h at the
same temperature described. After the addition of aqueous NH4Cl, the mixture
was extracted with Et2O. The organic extract was washed with saturated
aqueous NaCl, and dried over MgSO4. Compound 10: 1H NMR (CDCl3) d 0.89
(6H, t, J = 6.8 Hz), 1.10–1.60 (16H, m), 1.23 (18H, s), 1.79 (2H, s), 4.34 (1H, s),
6.75 (2H, s). The conversions were estimated through the ratio of the
integration of an olefinic proton in starting material 9 [d 6.61 (2H, s)] and an
olefinic proton in target material 10 [d 6.75 (2H, s)]. The yields were
determined with anthracene as an internal standard.
Acknowledgments
8. Representative examples regarding the use of MgBr2, see: (a) Swain, C. G.;
Boyles, H. B. J. Am. Chem. Soc. 1951, 73, 870; (b) Wotiz, J. H.; Hollingsworth, C.
A.; Dessy, R. E. J. Org. Chem. 1956, 21, 1063; (c) Holm, T. Acta Chem. Scand. 1967,
21, 2753; (d) Ashby, E. C.; Chao, L.-C.; Neumann, H. M. J. Am. Chem. Soc. 1973,
95, 4896; (e) Yamazaki, S.; Yamabe, S. J. Org. Chem. 2002, 67, 9346. and
references cited therein; for MgCl2: e.g. (f) Sobota, P.; Duda, B. J. Organomet.
Chem. 1987, 332, 239; Concentration and solvents used have also influence on
Schlenk equilibrium, see: (g) Smith, M. B.; Becker, W. E. Tetrahedron 1966, 22,
3027.
M.M. thanks Dr. Kunio Ogasawara, Professor Emeritus, Tohoku
University, for helpful suggestions for this study and preparation
of the manuscript. Thanks are also due to Dr. Masahiro Kato, Dep-
uty Department Manager of API Process Development Department,
Mr. Toshiro Kozono, Department Manager of API Process Develop-
ment Department, and Dr. Hidetoshi Ushio, General Manager of
Pharmaceutical Technology Division of Chugai Pharmaceutical
Co., Ltd, for their support of this work.
9. MgBr2 in Et2O was a suspension, however, it became a clear solution as
PenMgBr was added indicating that a mixed aggregation of PenMgBr–MgBr2
would take place in Et2O.
10. The structure of compound 13 was deduced from a 1H NMR analysis of its
crude product: 1H NMR (CDCl3) d 0.87 (6H, t, J = 6.5 Hz), 1.2–1.5 (16H, m), 1.42
(s, 9H), 1.57 (s, 9H), 3.3(2H, s), 4.8(OH, 1H, s), 6.82 (1H, s).
References and notes
11. Related cyclization of hydroquinone or its keto tautomer, see: (a) Cohen, N.;
Lopresti, R. J.; Neukom, C. J. Org. Chem. 1981, 46, 2445; (b) The reaction could
proceed under aqueous acidic conditions (e.g., a solution of citric acid) to give
the desired product though capriciously perhaps due to bi-phase reactions.
1. (a) Tamura, K.; Kato, Y.; Ishikawa, A.; Kato, Y.; Himori, M.; Yoshida, M.;
Takashima, Y.; Suzuki, T.; Kawabe, Y.; Cynshi, O.; Kodama, T.; Niki, E.; Shimizu,
M. J. Med. Chem. 2003, 46, 3083; (b) Noguchi, N.; Iwaki, Y.; Takahashi, M.;